07 Nov Researchers Turn To Experimental Medication to Boost the efficacy of Chemotherapy Against Mesothelioma
Researchers are turning into a experimental, metal-based anti-cancer medication to boost the efficacy of chemotherapy in patients. While chemotherapy is employed in treating almost all pleural mesothelioma patients, the cancer eventually develops a resistance to the medication making them ineffective. But, by treating the individual with the ruthenium-containing medication RAPTA-T, the cancerous tumors might readily absorb the chemotherapy and also impede the development. A group of researchers in the Centre Hospitalier Universitaire Vaudois, Switzerland, and the Swiss Federal Institute of Technology, decided that in order to Work, chemotherapy drugs should first reach the tumor together with […]
The article Researchers Turn To Experimental Drug to Improve The Effectiveness of Chemotherapy Against Mesothelioma appeared initially on Mesothelioma Help Cancer Organization.